Michael DeFee
Research Subjects
Michael DeFee has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Borbola
Department of Restorative Dentistry and Endodontics, Faculty of Dentistry, Semmelweis University, Szentkirályi utca 47, H-1088, Budapest, Hungary
5 shared publications - János Vág
Department of Restorative Dentistry and Endodontics, Faculty of Dentistry, Semmelweis University, Budapest, Hungary
5 shared publications Gyorgy Sersli
Dental technicians, Artifex Dentis Kft. Révay utca 12, H-1065 Budapest, Hungary
3 shared publicationsWalter Renne
3 shared publications- Allan Queiroz
The MOD Institute, 320 Broad St. #210 Charleston, SC 29401, United States
2 shared publications - Laszlo Romanszky
Dental technicians, Artifex Dentis Kft. Révay utca 12, H-1065 Budapest, Hungary
2 shared publications
Latest Publications
- Open Access
- 27 July 2026
- Published by Elsevier in Journal of Dentistry
- Vol. 175
Effect of candy coating and post-processing protocols on the cytotoxicity, surface roughness, and hardness of 3D-printed definitive resins
- 27 July 2026
- Published by Elsevier in Journal of Dentistry
- Vol. 175
Open AccessEffect of candy coating and post-processing protocols on the cytotoxicity, surface roughness, and hardness of 3D-printed definitive resins
- Top Cited PapersOpen Access
- 1 April 2026
- Published by Elsevier in Journal of Dentistry
- Vol. 170, 106668
Virtual-fit assessment of full-arch implant photogrammetry accuracy in a human cadaver model
- 1 April 2026
- Published by Elsevier in Journal of Dentistry
- Vol. 170, 106668
Top Cited PapersOpen AccessVirtual-fit assessment of full-arch implant photogrammetry accuracy in a human cadaver model
- Open Access
- 31 July 2024
- Published by Elsevier in Journal of Dentistry
- Vol. 149, 105281
Complete-arch accuracy of seven intraoral scanners measured by the virtual-fit method
- 31 July 2024
- Published by Elsevier in Journal of Dentistry
- Vol. 149, 105281
Open AccessComplete-arch accuracy of seven intraoral scanners measured by the virtual-fit method
- Open Access
- 20 November 2023
- Published by Elsevier in Journal of Dentistry
- Vol. 141, 104780
Application of the virtual-fit method for fixed complete denture cases designed on intraoral scans: Effect of cement spacing
- 20 November 2023
- Published by Elsevier in Journal of Dentistry
- Vol. 141, 104780
Open AccessApplication of the virtual-fit method for fixed complete denture cases designed on intraoral scans: Effect of cement spacing
- Top Cited PapersOpen Access
- 19 December 2022
- Published by Elsevier in Journal of Dentistry
- Vol. 129, 104391
In vitro comparison of five desktop scanners and an industrial scanner in the evaluation of an intraoral scanner accuracy
- 19 December 2022
- Published by Elsevier in Journal of Dentistry
- Vol. 129, 104391
Top Cited PapersOpen AccessIn vitro comparison of five desktop scanners and an industrial scanner in the evaluation of an intraoral scanner accuracy
- Open Access
- 1 January 2013
- Published by American Society for Microbiology in Journal of Virology
- Vol. 87 (1) , 621-635
Kaposi's Sarcoma-Associated Herpesvirus Suppression of DUSP1 Facilitates Cellular Pathogenesis following De Novo Infection
Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi's sarcoma (KS), and KSHV activation of mitogen-activated protein kinases (MAPKs) initiates a number of key pathogenic determinants of KS. Direct inhibition of signal transduction as a therapeutic approach presents several challenges, and a better understanding of KSHV-induced mechanisms regulating MAPK activation may facilitate the development of new treatment or prevention strategies for KS. MAPK phosphatases, including dual-specificity phosphatase-1 (DUSP1), negatively regulate signal transduction and cytokine activation through MAPK dephosphorylation or interference with effector molecule binding to MAPKs, including the extracellular signal-regulated kinase (ERK). We found that ERK-dependent latent viral gene expression, the induction of promigratory factors, and cell invasiveness following de novo infection of primary human endothelial cells are in part dependent on KSHV suppression of DUSP1 expression during de novo infection. KSHV-encoded miR-K12-11 upregulates the expression of xCT (an amino acid transporter and KSHV fusion/entry receptor), and existing data indicate a role for xCT in the regulation of 14-3-3β, a transcriptional repressor of DUSP1. We found that miR-K12-11 induces endothelial cell secretion of promigratory factors and cell invasiveness through upregulation of xCT-dependent, 14-3-3β-mediated suppression of DUSP1. Finally, proof-of-principle experiments revealed that pharmacologic upregulation of DUSP1 inhibits the induction of promigratory factors and cell invasiveness during de novo KSHV infection. These data reveal an indirect role for miR-K12-11 in the regulation of DUSP1 and downstream pathogenesis.
- 1 January 2013
- Published by American Society for Microbiology in Journal of Virology
- Vol. 87 (1) , 621-635
Open AccessKaposi's Sarcoma-Associated Herpesvirus Suppression of DUSP1 Facilitates Cellular Pathogenesis following De Novo Infection
Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi's sarcoma (KS), and KSHV activation of mitogen-activated protein kinases (MAPKs) initiates a number of key pathogenic determinants of KS. Direct inhibition of signal transduction as a therapeutic approach presents several challenges, and a better understanding of KSHV-induced mechanisms regulating MAPK activation may facilitate the development of new treatment or prevention strategies for KS. MAPK phosphatases, including dual-specificity phosphatase-1 (DUSP1), negatively regulate signal transduction and cytokine activation through MAPK dephosphorylation or interference with effector molecule binding to MAPKs, including the extracellular signal-regulated kinase (ERK). We found that ERK-dependent latent viral gene expression, the induction of promigratory factors, and cell invasiveness following de novo infection of primary human endothelial cells are in part dependent on KSHV suppression of DUSP1 expression during de novo infection. KSHV-encoded miR-K12-11 upregulates the expression of xCT (an amino acid transporter and KSHV fusion/entry receptor), and existing data indicate a role for xCT in the regulation of 14-3-3β, a transcriptional repressor of DUSP1. We found that miR-K12-11 induces endothelial cell secretion of promigratory factors and cell invasiveness through upregulation of xCT-dependent, 14-3-3β-mediated suppression of DUSP1. Finally, proof-of-principle experiments revealed that pharmacologic upregulation of DUSP1 inhibits the induction of promigratory factors and cell invasiveness during de novo KSHV infection. These data reveal an indirect role for miR-K12-11 in the regulation of DUSP1 and downstream pathogenesis.